Acupuncture May Alleviate Nocturia in Men Treated for Prostate Cancer
By Lori Solomon HealthDay Reporter
TUESDAY, June 3, 2025 -- Acupuncture may reduce nocturia in patients treated for prostate cancer, according to a research letter published online May 29 in JAMA Oncology.
Kevin T. Liou, M.D., from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues conducted a randomized trial to evaluate acupuncture (10 weekly standardized treatments) relative to usual care for nocturia in prostate cancer survivors. The analysis included 60 participants with treated prostate cancer who reported two or more nocturia episodes every night for the past month.
The researchers found that acupuncture (40 participants) produced greater reduction in nocturia episodes than the waiting-list control (20 participants) by the end of treatment at week 10 (between-group difference, −1.13), which persisted up to one month posttreatment (difference, −0.85). Acupuncture was also associated with greater reduction in International Prostate Symptom Score total scores versus control at week 10 (difference, −3.76), which persisted until week 14 (difference, −3.39). Among those assigned to acupuncture, the most common adverse events were dizziness (mild, 2) and insomnia (mild, 2), with no cases reported in the control group.
"The promising effects of acupuncture on nocturia warrant further investigation in larger trials to address a substantial unmet need among survivors of prostate cancer," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2025
Read this next
Opportunistic Community Screening IDs Uncontrolled Cardiovascular Risk Factors
FRIDAY, Aug. 15, 2025 -- Opportunistic pop-up community screening identifies a high prevalence of uncontrolled cardiovascular risk factors, according to a study published online...
Missed Opportunity Common in Patients With High-Grade Serous Ovarian Cancer
FRIDAY, Aug. 15, 2025 -- A considerable proportion of patients with high-grade serous cancer (HGSC) have missed opportunities for risk assessment with genetic testing and for...
EHR Notes Reveal Potential Racial Bias in Doctors' Perception of Patient Credibility
FRIDAY, Aug. 15, 2025 -- An analysis of more than 13 million electronic health record (EHR) notes shows potential racial bias in how doctors document patient trustworthiness...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.